| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |